Pfizer Inc. buy cbetz100
Start price
30.11.20
/
50%
€31.50
Target price
30.11.21
€38.00
Performance (%)
18.40%
End price
02.08.21
€36.33
Summary
This prediction ended on 02.08.21 with a price of €36.33. The prediction had a final performance of 18.40%. Dividends of €0.97 are taken into consideration when calculating the performance. cbetz100 has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Pfizer Inc. | -0.115% | -0.115% | -17.871% | -28.671% |
iShares Core DAX® | -1.114% | 3.430% | 25.966% | 25.039% |
iShares Nasdaq 100 | 1.816% | 6.911% | 30.390% | 48.139% |
iShares Nikkei 225® | 2.113% | 5.501% | 23.404% | 11.979% |
iShares S&P 500 | 2.038% | 5.327% | 30.881% | 46.982% |
According to cbetz100 what are the pros and cons of Pfizer Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Very high dividend yield expected
Fair valuation
Higher EBIT margin than peer group
EBIT growth >5% per year expected
Revenue growth >5% per year expected
positive Cash Flow expected
Good rating
High Investments for future growth
Valuable balance sheet
Very differentiated customer and product portfolio
Growths faster than the competition
Medium risks for its business
Innovative
Top 10 in its market
Known brand
Future proof or reliable business model
Cons
Comments by cbetz100 for this prediction
In the thread Pfizer Inc. diskutieren
Buy mit Kursziel 38,0
Bisher die Corona-Aktie, die am wenigsten profitiert hat (Zusammenarbeit mit BioNtech).
Warum?
Weil die potentiellen Gewinne aus einem Covid-19 Impfstoff nur ein weiterer von bereits vielen Blockbustern wären?
Nun, damit kann ich leben :) Mit einer Dividendenrendite von >4% (ohne Impfstoff) auch.
Also legt Euch doch ein wenig Viagra ins Depot...
Warum?
Weil die potentiellen Gewinne aus einem Covid-19 Impfstoff nur ein weiterer von bereits vielen Blockbustern wären?
Nun, damit kann ich leben :) Mit einer Dividendenrendite von >4% (ohne Impfstoff) auch.
Also legt Euch doch ein wenig Viagra ins Depot...